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Autophagy, lipophagy, and mitophagy are considered to be the major recycling
processes for protein aggregates, excess fat, and damaged mitochondria in adipose
tissues in response to nutrient status-associated stress, oxidative stress, and genotoxic
stress in the human body. Obesity with increased body weight is often associated with
white adipose tissue (WAT) hypertrophy and hyperplasia and/or beige/brown adipose
tissue atrophy and aplasia, which significantly contribute to the imbalance in lipid
metabolism, adipocytokine secretion, free fatty acid release, and mitochondria function.
In recent studies, hyperactive autophagy in WAT was observed in obese and diabetic
patients, and inhibition of adipose autophagy through targeted deletion of autophagy
genes in mice improved anti-obesity phenotypes. In addition, active mitochondria
clearance through activation of autophagy was required for beige/brown fat whitening –
that is, conversion to white fat. However, inhibition of autophagy seemed detrimental
in hypermetabolic conditions such as hepatic steatosis, atherosclerosis, thermal injury,
sepsis, and cachexia through an increase in free fatty acid and glycerol release from
WAT. The emerging concept of white fat browning–conversion to beige/brown fat–
has been controversial in its anti-obesity effect through facilitation of weight loss and
improving metabolic health. Thus, proper regulation of autophagy activity fit to an
individual metabolic profile is necessary to ensure balance in adipose tissue metabolism
and function, and to further prevent metabolic disorders such as obesity and diabetes.
In this review, we summarize the effect of autophagy in adipose tissue browning in the
context of obesity prevention and its potential as a promising target for the development
of anti-obesity drugs.
Keywords: autophagy, lipophagy, mitophagy, beige/brown adipose tissue, browning, white adipose tissue,
whitening, obesity
INTRODUCTION: AUTOPHAGY IN ADIPOCYTES
Autophagy
Macroautophagy, generally referred to as autophagy, is a cytosolic degradation and recycling
process of damaged organelles and unwanted components in the cell (Singh et al., 2009b; Zhang
et al., 2012; Cairo et al., 2016). When the cells or tissues are limited in their nutrient supply or
exposed to a substantial amount of environmental, oxidative, or genotoxic stresses, autophagy
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as a cellular survival and defense mechanism can be activated
(Zhang et al., 2012; Bluher, 2013; Choi et al., 2013; Cairo
et al., 2016). Autophagy can be induced in the cell through
inhibition of either the nutrient-sensing kinase, mechanistic
target of rapamycin complex 1 (mTORC1), or the activating-
stress-sensing kinase, 5′-AMP activated protein kinase (AMPK)
(Jung et al., 2010; Kim et al., 2011; Stienstra et al., 2014).
On the other hand, when cells or tissues are supplied with
excessive nutrients, the autophagy process is not necessary and
is attenuated through mTORC1 activation and AMPK inhibition
(Jung et al., 2010; Kim et al., 2011; Stienstra et al., 2014). When
autophagy is suppressed for an extended period of time from
continuous overnutrition, as with a high fat and/or fructose
diet, the accumulation of unwanted proteins and organelles in
the major metabolic tissues – such as adipose, liver, muscle,
and pancreas – can become detrimental and eventually induce
metabolic dysfunction and diseases such as obesity and diabetes
(Zhang et al., 2012; Bluher, 2013; Rocchi and He, 2015). However,
contradictory to findings of previous studies, autophagy seems
hyperactivated in an effort to generate more fats from recycled
energy in adipose tissues of obese patients (Kovsan et al., 2011;
Jansen et al., 2012). A few reports suggest that autophagy
inhibition can be a protective mechanism against high-fat diet-
induced metabolic dysfunction by converting white adipose
tissue (WAT) to brown adipose tissue (BAT) (Armani et al.,
2014; Parray and Yun, 2017). Throughout the last decade,
the therapeutics of modulating autophagy activity have drawn
much attention; however, their clinical effectiveness in improving
the metabolic profiles of humans with adipocyte metabolic
dysfunctions linked to overweight, obesity, and diabetes has not
been ascertained (Shoji-Kawata et al., 2013; Galluzzi et al., 2017).
Adipogenesis
Adipogenesis is a unique adipocyte differentiation process
that generates lipid droplets with triglycerides and fatty acids
inside the lipid vacuoles (Rosen and Spiegelman, 2006; Ro
et al., 2013; Ahmed et al., 2018). Autophagy for non-selective
bulk degradation of proteins and lipids through the fusion of
autophagosomes and lysosomes is suggested as one of the major
types of autophagy in adipocytes (Singh et al., 2009b; Singh
and Cuervo, 2012; Ro et al., 2013). The relationship between
adipogenesis and autophagy has drawn much attention over the
past decade regarding the potential link to metabolic diseases
such as obesity. Autophagy is necessary and activated when
white adipocyte undergoes differentiation (Singh et al., 2009b;
Singh and Cuervo, 2012; Zhang et al., 2012; Ahmed et al.,
2018). Chloroquine treatment and autophagy-related protein
(ATG) 5 knockdown decreases adipogenesis of mouse embryonic
fibroblast (MEF) cells. Targeted deletion of ATG5 in mice leads
to a dramatically reduced mass of Perilipin A-positive white
adipocytes in late-stage embryos and neonatal pups (Baerga et al.,
2009; Singh et al., 2009b). Singh et al. and other research groups
also observed decreased levels of microtubule-associated protein
1A/1B-light chain 3 (LC3), peroxisome proliferator-activated
receptor (PPAR)- γ, and triglyceride. This finding indicates that
adipocyte differentiation and lipid accumulation are blocked
by inhibition of autophagy when ATG7 is knocked down in
adipocytes or in adipose-specific deletion in mice (Singh et al.,
2009b; Zhang et al., 2009; Singh and Cuervo, 2012). When
ULK1, the mammalian homolog of ATG1 and the downstream
autophagy kinase target of mTORC1, is knocked down in 3T3-L1
white adipocytes, adipogenesis increases, although autophagy is
inhibited. However, the ULK2 knockdown in white adipocytes
blocks both autophagy and adipogenesis (Ro et al., 2013). An
increase in autophagy has been reported in adipose tissues
derived from obese humans and mice, supporting adipogenesis in
forming and storing more fat depots in the face of overnutrition
(Kovsan et al., 2011; Cummins et al., 2014; Kosacka et al.,
2015). Both an increased level of the lipidated form of LC3
(LC3-II) as an autophagosome marker and a decreased level of
ubiquitin-binding scaffold protein p62, also called sequestosome
1(SQSTM1), were observed in obese humans and mice, the
combination of which would appear to be consistent with an
increase in autophagy activity during adipogenesis (Klionsky
et al., 2016; Yoshii and Mizushima, 2017). The level of autophagy
activity seems to differ or at least to fluctuate depending on the
adipose tissue type, external stimuli, and tissue age (Bluher, 2013;
Kosacka et al., 2015; Li and Ding, 2017). Autophagy is activated
when white adipocyte is undergoing differentiation to form lipid
droplets. However, in an opposite way, autophagy also can be
inhibited when brown adipocyte is activated with UCP1 and
PPAR-γ, increasing thermogenesis and browning, respectively,
under cold exposure (Singh and Cuervo, 2012; Cairo et al., 2016;
Ferhat et al., 2018). Based on previous studies on autophagy in
different types of adipocytes, the inhibition of autophagy seems to
be better for obesity prevention by reducing the formation of lipid
droplets in white adipocytes and promoting energy expenditure
in beige or brown adipocytes (Singh et al., 2009b; Kovsan et al.,
2011; Ro et al., 2013; Cairo et al., 2016).
Adipocytes
Adipocytes are the main type of cells found in both white
and brown adipose tissues (Lo and Sun, 2013). White
adipocytes contain a single lipid droplet and a small number
of mitochondria. Brown adipocytes contain multiple small lipid
droplets, enriched amounts of mitochondria, and exhibit a
unique thermogenesis function through uncoupling protein
1 (UCP1). Beige adipocytes are the brown-like cells located
within WAT, and they have a higher expression level of
UCP1 than white adipocytes (Wu et al., 2012; Lo and Sun,
2013; Armani et al., 2014; Cummins et al., 2014). Browning
is a process of dynamic conversion or modification of white
adipocytes into beige/brown adipocytes upon activation by
exposure to physiological, pharmacological, or hormonal stimuli
(Wu et al., 2013; Abdullahi and Jeschke, 2016). Browning of white
adipocytes is generally induced under cold exposure and exercise
(Wu et al., 2012; Lo and Sun, 2013; Aldiss et al., 2018). However,
this process does not completely transform or transdifferentiate
white adipocytes into brown adipocytes. The white adipocytes
become only a brown adipocyte-like phenotype, which is also
called beige, inducible brown, brown-in-white, or brite adipocyte
(Bartelt and Heeren, 2014; Scheele and Nielsen, 2017). In mouse
studies, more beige cells have been detected in WAT of lean,
compared to obese mice (Rachid et al., 2015). However in
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human studies, they only observed higher native BAT activity
but not active beige cells in lean subjects (Vijgen et al., 2011).
Conventional methods to increase UCP1 in beige/brown fat
cells, such as cold acclimation in humans, have not revealed any
inducible browning fat depots in addition to the constitutively
present depots and have not also proven enough to mediate
browning of white fat depots (Scheele and Nielsen, 2017). There
indeed are a few reports on cold-induced browning of human
perirenal fat, but whether this fat depot is a good representation
of visceral fat still remains controversial (Betz et al., 2013). In the
study of human patients with pheochromocytoma disease who
had performed both 18F-fluorodeoxyglucose positron emission
tomography/computed tomography (18F-FDG PET/CT) and
plasma total metanephrine (TMN) measurements in China,
browning of human visceral fat has been observed and reduces
whole body fat mass by burning more fats through increased
UCP1 in beige cells or BAT (Wang et al., 2011). Additionally,
recent studies suggest that browning can increase the basal
metabolism by burning fat through UCP1 and has been proposed
as a potential approach for reducing body fat or treating obesity
(Wu et al., 2012; Cummins et al., 2014).
Autophagy Types in Adipocytes
Adipocytes undergo three major types of autophagy:
macroautophagy, macrolipophagy (generally referred as
lipophagy), and mitophagy. These occur dynamically depending
on browning status (Baerga et al., 2009; Singh et al., 2009b;
Zhang et al., 2009; Singh and Cuervo, 2012; Li and Ding, 2017;
Ghosh et al., 2018). Both autophagy malfunction and adipocyte
dysfunction are clearly connected with the causes of metabolic
disorders such as obesity and diabetes (Baerga et al., 2009; Singh
et al., 2009b; Zhang et al., 2009; Bjorndal et al., 2011; Singh and
Cuervo, 2012; Bluher, 2013; Scheele and Nielsen, 2017; Ghosh
et al., 2018). To examine this, both mechanistic and clinical
studies have investigated the significant relationship between
autophagy and browning (Armani et al., 2014; Stienstra et al.,
2014). Here, we summarize the following: 1) the three major
types of autophagy and their significance in regulating adipose
lipid and energy metabolism; and 2) autophagy manipulations
through direct autophagy gene knockdown or chemical/drug
administration affecting the browning process in humans and
mice from previous publications.
LIPOPHAGY IN ADIPOCYTE LIPID
METABOLISM
Lipophagy is the selective removal of lipid droplets in cytosolic
organelles by lysosomes, which are derived from stimulated
autophagy markers such as LC3 and p62 (Singh and Cuervo,
2012; Ward et al., 2016). Lipogenesis, often considered identical
to adipogenesis, is focused on the formation of lipid droplets
during white adipocyte differentiation with autophagy activation;
lipolysis, on the other hand, is the secretion of glycerol and fatty
acid partially resulting from the degradation of lipid droplets by
autophagy (Cingolani and Czaja, 2016; Ahmed et al., 2018). The
balance between lipogenesis and lipolysis plays a vital role in
regulating the lipid metabolism in white and brown adipocytes
(Singh and Cuervo, 2012; Martinez-Lopez et al., 2016; Zechner
et al., 2017). ULK1 activates lipolysis by activating autophagy in
3T3-L1 adipocytes. However, ULK1 inhibits fatty acid synthesis
and uptake and activates fatty acid oxidation in the mitochondria
independent of autophagy in adipocytes (Ro et al., 2013). In
an in vivo study of POMC neurons using C57BL/6 WT mice,
lipophagy in BAT and liver was activated by both cold exposure
and rapamycin administration via the specific surface protein
of lipid droplets, adipose triglyceride lipase (ATGL), and LC3
association (Martinez-Lopez et al., 2016). Although both liver
and adipose tissue are important tissues in regulating lipid
metabolism (Martinez-Lopez et al., 2016), when lipophagy was
blocked in liver-specific ATG7 knockout mice, the lipid droplets
accumulated in the liver and showed a steatosis-like phenotype
(Singh and Cuervo, 2012; Liu and Czaja, 2013). However, in the
case of adipose-specific ATG7 knockout mice, white adipocytes
showed more brown adipocyte phenotypes with decreased lipids,
increased number of mitochondria and beta oxidation (Singh
et al., 2009b; Zhang et al., 2009).
The mechanism underlying different tissue specificity is
still unclear (Singh and Cuervo, 2012; Martinez-Lopez et al.,
2016). When basal lipophagy is inhibited by hyperactivation of
mTORC1 due to overnutrition in the human body, lipid droplets
are rapidly accumulated in BAT and liver (Singh et al., 2009a). By
contrast, when inducible lipophagy is enhanced by inhibition of
mTORC1 and activation of AMPK under starvation, lipophagy
actively degrades lipid droplets in WAT and releases them as free
fatty acids so that other metabolic tissues such as liver and muscle
can utilize them as an energy source (Rosen and Spiegelman,
2006; Liu and Czaja, 2013; Ward et al., 2016). Thus, the balance
between basal lipophagy and inducible lipophagy, as well as the
balance between lipogenesis and lipolysis, is important and seems
to be a possible mechanism explaining tissue specificity. BAT and
liver tissue would be more prone to the balance between the basal
and inducible status of lipophagy, whereas WAT would be more
prone to the balance between lipogenesis and lipolysis. These
different sensitivities and availability of lipophagy according to
the type of tissues and stimuli may create advantages by allowing
it to quickly adapt to the different levels of nutrient status in the
human body (Martinez-Lopez et al., 2016; Ward et al., 2016).
In future studies, transgenic mice with an inducible lipophagy
system may serve as a very plausible model for identifying
lipophagy specificity and its effect on lipid contents depending
on nutrient availability (Singh and Cuervo, 2012).
MITOPHAGY IN ADIPOCYTE
MITOCHONDRIA FUNCTION
Mitophagy is the process of actively removing excess
mitochondria through selective autophagy when mitochondria
have accumulated during differentiation or have been damaged
by oxidative stress such as ROS (Zhang et al., 2012; Ashrafi
and Schwarz, 2013; Li et al., 2015; Taylor and Gottlieb, 2017).
Mitophagy can be induced by ULK1 upon AMPK activation
or mTORC1 inhibition under cellular maturation or nutrient
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deprivation (Kundu et al., 2008; Egan et al., 2011; Kim et al.,
2011). The main mitophagy process, the association between
mitochondria and autophagolysosomes, is mediated by the
ubiquitin-dependent PINK1-Parkin pathway (Narendra et al.,
2010; Vincow et al., 2013; Bingol and Sheng, 2016). Alternatively,
mitochondria can be degraded by selective autophagy via LC3
and p62 protein independent of ubiquitin in adipose tissue
(Altshuler-Keylin and Kajimura, 2017; Taylor and Gottlieb,
2017; Lu et al., 2018). Mitochondria can also be degraded
and decreased in number through mitophagy to form more
lipid droplets in white adipocyte tissue during differentiation
by limiting fatty acid oxidation (Gospodarska et al., 2015;
Altshuler-Keylin and Kajimura, 2017). Mitophagy at least in
part contributes to whitening of beige adipocytes, turning
them into white adipocytes by removing mitochondria after
the withdrawal of cold exposure (Altshuler-Keylin et al.,
2016; Altshuler-Keylin and Kajimura, 2017; Lu et al., 2018).
Therefore, when mitophagy is blocked in white adipocytes,
mitochondria cannot be degraded and accumulated while
inhibiting adipogenesis, which results in a beige/brown
adipocyte phenotype (Altshuler-Keylin and Kajimura, 2017).
Consistent with cell culture studies, when mitophagy is inhibited
in mice either by autophagy gene deficiency or chemical
administration, WAT shows accumulation of mitochondria
with decreased fat mass and changes into a phenotype like
the beige or brown adipocytes (Singh and Cuervo, 2012;
Altshuler-Keylin et al., 2016; Taylor and Gottlieb, 2017; Lu et al.,
2018). Clinical researchers have observed more accumulation
of dysfunctional or metabolically impaired mitochondria in
obese people compared to a lean control group (Kraunsoe
et al., 2010; Chattopadhyay et al., 2015). These observations
possibly suggest that mitophagy would be negatively regulated by
excessive fat accumulation or in obese condition. In conditions
of overnutrition, mTORC1 activation and mitophagy inhibition
resulted in greater accumulation of impaired mitochondria
(Altshuler-Keylin and Kajimura, 2017). Studies using autophagy-
related gene knockout mice fed with a high-fat diet suggest that
when autophagy and mitophagy in adipocytes are impaired
by overnutrition, inhibition of lipogenesis and activation of
lipophagy can occur as a compensatory mechanism (Zhang et al.,
2009; Altshuler-Keylin and Kajimura, 2017). To our surprise,
the browning of WAT was observed in skeletal muscle-specific
Atg7 knockout mice that were resistant to obesity induced by a
high-fat diet (Kim et al., 2013). This ambivalence of mitophagy
in adipocyte turnover and the existence of compensation
mechanisms with other selective autophagy may be for purposes
of more effectively maintaining mitochondrial integrity and
mass in adipocytes (Lu et al., 2018). Although mitophagy is
suggested as a positive regulator of white adipogenesis and a
negative regulator of beige and brown adipogenesis, the level of
mitophagy necessary for browning seems controversial due to
the complicated regulation of activity dependent on nutrition
status (Altshuler-Keylin and Kajimura, 2017). Therefore, the
proper modulation of mitophagy in adipocytes in humans
and mice seems necessary for the timely turnover between
white, beige, and brown adipocytes, dependent on nutrition
level.
AUTOPHAGY MANIPULATIONS IN
ADIPOCYTE BROWNING
Although the distribution of adipose tissue is distinct in
humans and mice, both share common characteristics (Seale
et al., 2009; Zhang et al., 2018). Anatomically in male mice,
interscapular brown adipose tissue (iBAT) contains classic
brown adipocytes, whereas epididymal white adipose tissue
(eWAT) and subcutaneous white adipose tissue (sWAT) contain
classic white adipocytes (Sanchez-Gurmaches and Guertin, 2014;
Gospodarska et al., 2015). In humans, most classic brown
adipocytes develop mainly around the neck and supraclavicular
area through infancy, but gradually decrease until adulthood
(Wu et al., 2012; Zhang et al., 2018). Several studies using
positron emission tomography (PET)-CT have demonstrated
that, in addition to size reduction in aging, BAT activity is
reduced in obese and diabetic patients (Lee et al., 2010; Leitner
et al., 2017). A few other clinical research groups have suggested
that stimulating browning in WAT would be beneficial in
slowing obesity, diabetes, and even the aging process (Scheele
and Nielsen, 2017). Therefore, the existence of active turnover
from WAT to beige fat to BAT in humans and mice has been
recognized as a potential therapeutic target for prevention and
treatment of obesity and related metabolic diseases (Kajimura
et al., 2015; Schrauwen et al., 2015; Giordano et al., 2016).
Even whole tissue switching of WAT to BAT through surgical
transplantation or implantation of mesenchymal stem cells,
brown adipocytes, or BAT into WAT areas in humans and
mice is gaining a new spotlight as a novel method to prevent
or treat obesity and diabetes (Liu et al., 2013; Soler-Vazquez
et al., 2018). However, the activity and selectivity of autophagy
after the transplantation or implantation still needs further
investigation.
Indeed, autophagy plays an important role in the browning
of WAT and beige adipocytes. A recent study has reported
that autophagy is needed to convert beige adipocytes to WAT
upon removal of β3-AR agonists or recovery from cold exposure
(Altshuler-Keylin et al., 2016). Cairo et al. (2016) reported
that thermogenic activation through cold exposure inhibits
autophagy, which leads to increased UCP1 level in BAT.
Although we have selected only a few significant factors to discuss
in our review, numerous factors are involved in the manipulation
of the autophagy pathway, which regulate the browning of WAT
and beige adipocyte (Table 1).
Parkin-Mediated Mitophagy in Browning
Parkin (gene name: Park2) is a E3 ubiquitin ligase that plays
a critical role in ubiquitination as a mitophagy-associated
degradation signal (Geisler et al., 2010; Jin and Youle, 2012;
Pickrell and Youle, 2015). The role of Parkin in browning of WAT
has been studied in 3T3-L1 adipocytes and the Parkin-deficient
C57BL/6 mice model. Parkin expression increases during 3T3-
L1 adipocyte differentiation, while its expression decreases in
rosiglitazone-treated 3T3-L1 adipocytes, which have phenotypes
of beige adipocytes due to enhanced UCP1 expression.
Inhibition of the Parkin gene does not affect browning, but
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TABLE 1 | Summary of recent studies about the effect of direct autophagy gene manipulation or autophagy-related regulators on adipocyte browning.
Study Target Gene Intervention Application Results Clinical/Physiological Function
Baerga et al., 2009;
Singh et al., 2009b
ATG5 In vitro
Chloroquine (autophagy inhibitor)
treatment in MEF cells (Baerga
et al., 2009)
siAtg5 (knockdown) in MEF cells
(Singh et al., 2009b)
In vivo
Histological analysis of Atg5−/−
late-stage embryos and neonatal
pups (Baerga et al., 2009)
Chloroquine treatment and
Atg5 knockdown decreased
adipogenesis of MEF cells
(Singh et al., 2009b).
Perilipin A positive adipocytes
in sWAT as dramatically
reduced in Atg5−/− late-stage
embryos and neonatal pups
(Baerga et al., 2009).
Chloroquine’s or Atg5’s effect
on browning is not observed.
Chloroquine increased success in an
autophagy-inhibitor based treatment
therapy for a variety of cancer types in
humans, when compared to chemotherapy
or radiation alone (Xu et al., 2018).
Singh et al., 2009b;
Zhang et al., 2009
ATG7 In vitro
siAtg7 in 3T3-L1 adipocytes (Singh
et al., 2009b)
In vivo
Adipose-specific Atg7−/− and WT
mice (both groups)
White adipocyte differentiation
is blocked upon Atg7 loss, and
mice showed brown adipocyte
phenotypes with decreased
lipids, increased number of
mitochondria and beta
oxidation.
N/A
Ro et al., 2013 ATG1 In vitro
Rapamycin treatment, siULK1 or
siULK2 in 3T3-L1 adipocytes
ULK1 or ULK2 is necessary for
autophagy induction in
adipocytes.
ULK1 negatively regulates
lipogenesis independent of
autophagy in adipocytes.
ULK1’s or ULK2’s effect on
browning is not investigated.
Rapamycin, a potent ATG1 activator
through mTORC1 inhibition, has been
shown to increase the rate of autophagy in
ischemic adipose derived stem cells used
during transplantation in humans,
promoting overall success of the surgical
implantation (Li et al., 2017).
Martinez-Lopez
et al., 2016
ATGL In vivo
Cold or rapamycin administration
on C57BL/6 WT mice
Both cold and rapamycin
administration in POMC neuron
activates lipophagy in BAT via
ATGL-LC3 association.
See above
Cairo et al., 2016;
Altshuler-Keylin
et al., 2016
UCP1 In vivo
Cold administration on C57BL/6
WT mice (Cairo et al., 2016)
Cold or β3-AR agonist
administration on
[UCP1(+)]-adipocyte-specific Atg5
or Atg12 knockout mice
(Altshuler-Keylin et al., 2016)
Activation of UCP1 suppresses
autophagy in BAT (Cairo et al.,
2016).
Atg5 or Atg12 knockout in
beige/brown adipose tissue
prevents white-like
characteristics through
inhibiting autophagic clearance
of mitochondria
(Altshuler-Keylin et al., 2016).
N/A
Taylor and Gottlieb,
2017; Lu et al.,
2018
PARKIN or PARK2 In vitro
Rosiglitazone (browning stimuli),
siParkin, or mCherry-Parkin
(overexpression) in 3T3-L1
adipocytes (Taylor and Gottlieb,
2017)
In vivo
Parkin−/− and WT mice with
rosiglitazone or CL316243 injection
(Taylor and Gottlieb, 2017)
In vivo
Park2 knockout mice administered
with β3-AR agonist, CL316243 (Lu
et al., 2018)
Rosiglitazone induces browning
in 3T3-L1 white adipocytes;
Parkin knockdown does not
affect browning, but Parkin
overexpression inhibits
browning in adipocytes (Taylor
and Gottlieb, 2017).
When browning stimulus
CL316243 was removed,
UCP1 was reduced in WAT of
WT, but was maintained in
Park2 knockout mice and BAT
of both groups (Lu et al., 2018).
Rosiglitazone, a PPAR-γ agonist, has been
shown to increase overall body fat content
in humans, but does not affect heart rate
variability (Grenier et al., 2016).
CL 316,243 has been shown to increase
the effectiveness of insulin, and fat
oxidation in lean male subjects, by acting
as an agonist for β3-adrenergic receptor
(Weyer et al., 1998).
Armani et al., 2014 Mineralocorticoid receptor
antagonist: spironolactone
(spiro) or drospirenone
(DRSP)
In vitro
3T3-L1 was differentiated with
10−8 M aldosterone, 10−5 M
DRSP or 10−5 M spiro treatment
In vivo
High-fat diet-fed mice with
white adipocytes, revealed by
increase of brown
adipose-specific markers such
as UCP1 and PRDM16.
Serum aldosterone reduction through diet
change and increase in physical activity has
been shown to decrease obesity-related
health factors in young adults only
diagnosed with excess body fat (Cooper
et al., 2013).
(Continued)
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TABLE 1 | Continued
Study Target Gene Intervention Application Results Clinical/Physiological Function
6 mg/kg/day DRSP or
20 mg/kg/day spiro for 90 days
Mineralocorticoid receptor
antagonists reduced body
weight gain and WAT mass
gain via autophagy activation,
but significantly increased
browning of WAT and primary
DRSP, an autophagy activator, currently has
no human clinical trials available.
Spiro was shown to rescue insulin
resistance in humans with chronic kidney
disease, and reversed glucose intolerance
in mice possibly by activating autophagy
(Hosoya et al., 2015).
Ghosh et al., 2018 PIK3C3 In vivo
Aged C57BL/6 male mice with
mutant PIK3C3 gene
PIK3C3 mutation led to
enhanced browning of gWAT
when autophagy is impaired.
N/A
Parray and Yun,
2017
Thiodigalactoside (TDG) In vitro
500 µM during 3T3-L1 and HIB1B
adipocyte differentiation
In vivo
5-week-old rats peritoneal injected
5 mg/kg/week for 5 weeks
TDG, an inhibitor of autophagy,
increases browning markers,
thermogenic protein UCP1, and
mitochondrial functions and
activities.
TDG currently has no clinical data available
in humans.
Leu et al., 2018 Raspberry ketone In vitro
100 µM for 48 hrs after fully
differentiated 3T3-L1 adipocytes
In vivo
8-week-old rats administered
160 mg/kg/day for 8 weeks
Raspberry ketone-fed rats had
less adipose tissue, more
browning-related markers
through inhibition of autophagy.
Currently, clinical data is not available in
humans for Raspberry ketone.
overexpression of Parkin significantly reduces browning in
adipocytes (Taylor and Gottlieb, 2017). Furthermore, Parkin
is highly expressed during beige adipocyte differentiation (Lu
et al., 2018). The Kajimura group has shown that Parkin
is required to maintain beige adipocytes in WAT. When
CL316243, a β3-AR agonist, is removed, UCP1 expression is
significantly reduced in WAT of wild type (WT) mice, but
still expressed in WAT of Park2 knockout mice. In contrast,
UCP1 expression in BAT is not changed in both WT and
Park2 knockout mice after CL316243 is removed (Lu et al.,
2018).
Mineralocorticoid Receptor Antagonism
in Browning
The Yan group has shown that autophagy is regulated by
mineralocorticoid receptor (MR) antagonism (Li et al., 2016).
Spironolacton induces LC3 and ATG5 expression and reduces
PI3K/AKT/mTOR pathways in injured human podocytes (Li
et al., 2016). Previous research has reported the role of MR
in adipocyte differentiation. Drospirenone (DRSP) significantly
reduces 3T3-L1 and 3T3-F442A adipocyte differentiation without
cell cytotoxicity (Caprio et al., 2011). MR also regulates
browning of WAT though autophagy. Additionally, it has been
determined that MR antagonists fully prevent aldosterone-
induced autophagy in white adipocytes along with an increase
of UCP1 expression. MR antagonists significantly enhance
browning of WAT in diet-induced obese mice as well as brown
adipose-specific markers in primary adipocytes isolated from
WAT (Armani et al., 2014).
PIK3C3 in Browning
PIK3C3 is a subunit of class III phosphoinositide 3-kindase
(PI3K) that phosphorylates phosphatidylinositol to generate
phosphatidylinositol 3-phosphate. The PIK3C3-ATG14 complex
induces autophagy especially in nutrient-stress conditions such
as starvation (Yuan et al., 2013). Recently, it has been shown
that in aged mice with a PIK3C3 mutation, compared to
fl/fl control mice, adipogenesis markers, such as AP2 and
C/EBP-α, are reduced, but brown adipose-specific markers, such
as UCP1 and PPAR- γ coactivator (PGC)1α, are enhanced
in both mRNA and protein levels in the gonadal WAT
(gWAT), possibly through blocking of autophagy (Ghosh et al.,
2018).
Thiodigalactoside in Browning
Thiodigalactoside (TDG), an inhibitor of galectin 1 and
autophagy, has recently been studied in obesity research by
the Yun group (Mukherjee et al., 2015; Parray and Yun,
2015; 2017). They have reported that TDG-treated adipocytes
significantly inhibit lipid accumulation, and TDG also reduces
body weight in high-fat diet-fed rats (Mukherjee et al., 2015).
Their second study has shown proteomic identification of
TDG in WAT of rats with high-fat diet-induced obesity.
Specifically, proteins involved in carbohydrate metabolism and
the tricarboxylic acid cycle remarkably increased in WAT of
TDG-injected obese rats (Parray and Yun, 2015). A most
recent study has reported that TDG plays an important role
in browning of white adipocytes and WAT in obese rats
(Parray and Yun, 2017). Dose-dependent TDG treatment reduces
galectin 1 and ATG 5 gene expression, but enhances brown-
specific markers, UCP1 and PGC1α, in 3T3-L1 adipocytes.
Moreover, UCP1 and PGC1α gene and protein expressions
are upregulated by PDG injection in iWAT, eWAT, and BAT
of diet-induced obese rats, possibly through inhibition of
ATG5/LC3-II and increase of p62 expression (Parray and Yun,
2017).
Frontiers in Physiology | www.frontiersin.org 6 January 2019 | Volume 10 | Article 22
fphys-10-00022 January 28, 2019 Time: 18:49 # 7
Ro et al. Autophagy in Adipocyte Browning
Raspberry Ketone in Browning
Raspberry ketone, 4-(4-hydroxyphenyl) butan-2-one, a phenolic
compound found in red raspberry, has emerged as a dietary
bioactive compound with beneficial effects on obesity (Cotten
et al., 2017; Tsai et al., 2017). Evidence suggests that raspberry
ketone reduces body weight and food intake in high-fat diet-
fed mice (Cotten et al., 2017) and ovariectomy-induced obese
rats (Leu et al., 2017). In addition, raspberry ketone inhibits
3T3-L1 adipogenesis, revealed by inhibition of expression of
adipogenesis markers such as PPAR-γ, C/EBP-α, FAS, and AP2,
possibly via inhibition of autophagy, confirmed by decrease
of ATG12 and LC3B levels, as well as increase of p62 and
mTORC1 levels (Leu et al., 2017; Tsai et al., 2017). It has
been recently reported that high concentration of raspberry
ketone (100 µM) significantly increases browning of 3T3-L1
adipocytes, revealed by an increase of browning-specific markers,
including UCP1 and PGC1α, and lipolysis markers such as
hormone-sensitive lipase and triglyceride lipase (Leu et al., 2018).
Moreover, expression of brown adipose markers is increased
in ovariectomy-induced obese rats that have been administered
raspberry, compared to control groups mediated by inhibition
of ATG12 and an increase of p62 expression (Leu et al.,
2018).
CONCLUSION: AUTOPHAGY- AND
BROWNING-TARGETING
THERAPEUTICS FOR THE PREVENTION
OF OBESITY
Adipose metabolism is closely linked with metabolic dysfunctions
such as obesity and diabetes when fat distribution and energy
balance through mitochondria are not strictly maintained
(Bjorndal et al., 2011; Bluher, 2013; Stienstra et al., 2014;
Scheele and Nielsen, 2017). The relationship between adipose
metabolism and autophagy has become an increasingly intriguing
topic since the dawn of the discovery of selective autophagy,
including lipophagy and mitophagy, which can also actively
occur in adipose tissue (Rocchi and He, 2015). Autophagy
has previously been shown to be increased in adipocytes from
obese humans and mice (Ost et al., 2010; Kovsan et al., 2011;
Jansen et al., 2012). Previous reports indicate that excess free
FIGURE 1 | Autophagy effect on adipocyte browning and potential therapeutic target for prevention of obesity. (A) Summary of the proposed effect of autophagy,
lipophagy, and mitophagy on adipocyte browning from recent studies. LV, lipid vacuoles; M, mitochondria; N, Nucleus. (B) Summary of the main characteristics of
WAT and BAT in obesity, and the induction of browning through manipulation of autophagy as a promising target for anti-obesity therapy.
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fatty acid (FFA) – particularly saturated FFA like palmitic acid
(PA), but not unsaturated FFA such as oleic acid (OA) –
formed by a high-fat diet can activate autophagy through
JNK2 or PKC activation (Tan et al., 2012; Tu et al., 2014).
Conversely, lipophagy seems beneficial for degrading excess
fats from WAT and generating more intracellular space for
the expansion of the mitochondrial contents from BAT when
mitophagy is inhibited or mitochondrial biogenesis is activated,
thus protecting the human body from nutrient oversupply
which, can occur in obesity conditions (Singh and Cuervo,
2012; Cummins et al., 2014). Mitophagy seems much more
controversial because basal activity can be beneficial through
elimination of damaged mitochondria from accumulated ROS in
obesity; however, hyperactive inducible mitophagy can convert
BAT or beige fat to white during differentiation, which is
called “reverse browning or whitening,” and subsequently cause
systemic change in adipocytokine release and lipid metabolism
(Hill et al., 2012; Gospodarska et al., 2015). Overall, inhibition
or deficiency of autophagy, activation of lipophagy rather than
lipolysis, and a basal or moderate level of mitophagy seems the
most optimal combination for the prevention of obesity so far
(Figure 1).
However, we have also encountered a few exceptional
cases from previous reports noting that hyperactive autophagy
can be beneficial during hypermetabolic conditions such
as hepatic steatosis, atherosclerosis, injuries from burning,
sepsis, and cachexia (Volzke et al., 2005; Penna et al., 2014;
Pravda, 2014; Song et al., 2014; Abdullahi and Jeschke, 2016).
Normally, hyperactivation of autophagy leads to apoptotic cell
death (Lum et al., 2005), but highly autophagic cells under
hypermetabolic conditions such as post-thermal injury may
survive better by efficiently regulating energy metabolism
(Auger et al., 2017). Paradoxically, autophagy activation
in WAT can be beneficial for obese or diabetic patients
with a hypermetabolic profile or complications, because
it decreases FFA and glycerol release from hypertrophic
and hyperplasic WAT by actively degrading lipid vacuoles
(LV) as an energy source. We have summarized previously
reported autophagy and selective autophagy manipulations
and their effect on adipocyte browning (Table 1). Since the
combined delicate manipulation of autophagy, lipophagy,
and mitophagy seems necessary for the timely turnover
between white, beige, and brown adipocytes dependent
on nutrition levels in humans and mice, the direct
manipulation of autophagy and selective autophagy or
the administration of autophagy-targeting drugs should
be cautiously performed. Finally, summarizing autophagy
regulation and its implications in browning could help give
insights for the development of autophagy-targeting drugs in
the prevention of obesity.
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